Kathryn O’Reilly

2.8k citations
15 papers · 2.2k indexed · 1 hit paper · h-index 7
Topics
RNA regulation and disease (3 papers)Skin Diseases and Diabetes (3 papers)Skin and Cellular Biology Research (2 papers)

In The Last Decade

Kathryn O’Reilly

15 papers receiving 2.2k citations

Hit Papers

mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase...2006202620122019200650010001.5k2.0k

Peers

Kathryn O’Reilly
Comparison fields: 5 of 90
  • Molecular Biology 1.8k
  • Oncology 563
  • Pulmonary and Respiratory Medicine 395
  • Pathology and Forensic Medicine 318
  • Cancer Research 273
Replace Sohye Kang with:
Sohye Kang United States
Cornelia Quadt Switzerland
Katherine E. Hutchinson United States
Heikki J. Helin Finland
Armelle Logié United Kingdom
Diana C. Birle Canada
Diana Mandelker United States
Josef Brueggen Switzerland
Natasha G. Deane United States
Nandini Dey United States
Kathryn O’Reilly relative to Sohye Kang United States Sohye Kang's profile →
Citations per field
00.5×1.5×
Sohye Kang · 1×
Citations per year

Countries citing papers authored by Kathryn O’Reilly

Since Specialization
Citations

This map shows the geographic impact of Kathryn O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn O’Reilly more than expected).

Fields of papers citing papers by Kathryn O’Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn O’Reilly. The network helps show where Kathryn O’Reilly may publish in the future.

Co-authorship network of co-authors of Kathryn O’Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn O’Reilly. A scholar is included among the top collaborators of Kathryn O’Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn O’Reilly. Kathryn O’Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 47
3 9
4 8
5
Chemical leukoderma - eScholarship
2
6
Chemical leukoderma.
5
7
Necrobiosis lipoidica.
3
8 12
9 4
10 5
11 12
12 4
13 4
14 54
15
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Aktbreakdown →
2037

About Kathryn O’Reilly

Kathryn O’Reilly is a scholar working on Dermatology, Cell Biology and Pathology and Forensic Medicine, having authored 15 papers that have together received 2.2k indexed citations. Recurring topics across this work include RNA regulation and disease (3 papers), Skin Diseases and Diabetes (3 papers) and Skin and Cellular Biology Research (2 papers). The work is most often cited by research in Molecular Biology (1.8k citations), Genetics (220 citations) and Oncology (563 citations). Kathryn O’Reilly has collaborated with scholars based in United States, Spain and Switzerland. Frequent co-authors include Gordon B. Mills, Neal Rosen, José Baselga, Dale L. Ludwig, Qing‐Bai She, Debra L. Smith, Daniel J. Hicklin, Francesco Hofmann, Heidi A. Lane and David B. Solit. Their work appears in journals such as Cancer Research, Clinical Cancer Research and Journal of Clinical Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026